4basebio PLC

88Q

Company Profile

  • Business description

    4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effectively and safely delivering these DNA-based products to patients. The company operates across three geographic segments: Europe, the United States, and the Rest of the World, with the majority of its revenue generated from the United States.

  • Contact

    25 Norman Way
    Over
    CambridgeCB24 5QE
    GBR

    T: +44 1223967943

    E: [email protected]

    https://www.4basebio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    140

Stocks News & Analysis

stocks

Undervalued REIT delivers strong earnings growth

ASX REIT remains undervalued despite result.
stocks

Disney earnings: Experiences and streaming again drive excellent results

We believe Disney’s irreplaceable characters will continue to drive a healthy experiences business, which we estimate is worth nearly as much as the market values the whole firm.
stocks

ASX utility share downgraded as electricity prices fall

Falling electricity prices weigh on earnings outlook for utility provider.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,452.0042.100.45%
CAC 408,699.7130.420.35%
DAX 4026,140.1313.830.05%
Dow JONES (US)53,966.66382.46-0.70%
FTSE 10010,867.8920.41-0.19%
HKSE25,530.28385.54-1.49%
NASDAQ26,377.9414.500.05%
Nikkei 22565,683.26617.18-0.93%
NZX 50 Index13,958.0639.12-0.28%
S&P 5007,720.562.99-0.04%
S&P/ASX 2009,271.6041.800.45%
SSE Composite Index3,900.3521.920.57%

Market Movers